Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
09/1998
09/02/1998CN1191748A Spray preparation for burns and scald and its preparation process
09/02/1998CN1191742A Epilepsy curing powder
09/02/1998CN1191741A Plaster for traumatic injury and its preparation
09/02/1998CN1191738A Huanyang oral liquid
09/02/1998CN1191737A Liniment Tongbining for cold-type arthralgia
09/02/1998CN1191735A Chinese medicine Yangshengbao and its production process
09/02/1998CN1191726A Medicine composite for curing digestive tract tumor and its preparation
09/02/1998CN1191725A Active doe placenta powder and its production process and product
09/02/1998CN1191724A Preparation of drained bear bile freeze-dried powder injection
09/01/1998US5801196 Methods of using emu oil and active fractions thereof as an insect repellent
09/01/1998US5801145 Method for selectively purging CD77+ cells from bone marrow
09/01/1998US5801044 Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions
09/01/1998US5801033 Gels for encapsulation of biological materials
09/01/1998US5801029 Cytopathic viruses for therapy and prophylaxis of neoplasia
09/01/1998US5801014 Growth differentiation factor-5
09/01/1998US5800980 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization
09/01/1998US5800829 Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
09/01/1998US5800828 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
09/01/1998US5800813 Treatment of cryptosporidium infections
09/01/1998US5800812 Methods of use of mononuclear phagocytes to promote axonal regeneration
09/01/1998US5800539 Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease
08/1998
08/28/1998CA2230490A1 Novel licc
08/27/1998WO1998037224A1 Transgenically produced non-secreted proteins
08/27/1998WO1998037217A1 A soluble vaccinia virus protein that binds chemokines
08/27/1998WO1998037190A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
08/27/1998WO1998037177A1 Isolated viable parasite intestinal cells
08/27/1998WO1998037098A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
08/27/1998WO1998036779A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow
08/27/1998WO1998036761A1 Anti-proliferative preparations
08/27/1998WO1998036760A1 Angiogenesis inhibitors and activators from shark cartilage
08/27/1998WO1998036759A1 Pharmaceutical compositions containing colostrum and the use of colostrum for the treatment of hair loss
08/27/1998WO1998036705A1 Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
08/27/1998WO1998036704A1 Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
08/27/1998WO1998013499A3 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
08/27/1998CA2288269A1 Angiogenesis inhibitors and activators from shark cartilage
08/27/1998CA2283090A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
08/27/1998CA2281949A1 Transgenically produced non-secreted proteins
08/27/1998CA2281911A1 Isolated viable parasite intestinal cells
08/27/1998CA2251645A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
08/26/1998EP0859957A2 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers
08/26/1998EP0859853A1 Method for transferring genes to the heart using aav vectors
08/26/1998EP0859847A1 Composition and method of imparting resistivity to hiv superinfection to cells
08/26/1998EP0859845A1 Novel cell surface protein compounds
08/26/1998EP0859837A2 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
08/26/1998EP0859830A2 Growth of adult pancreatic islet cells with laminin 5
08/26/1998EP0859640A1 Method for restoring glucose responsiveness to insulin secretion
08/26/1998EP0859639A1 Methods for treating cancers and restenosis with p21
08/26/1998EP0859638A1 Method for inhibiting cell-mediated killing of target cells
08/26/1998EP0859636A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
08/26/1998EP0859622A1 Extracts of shark cartilage
08/26/1998EP0859552A1 Liquid colostrum for dairy products
08/26/1998CN1191125A Medicinal composition for treating chronic obstructive disease of lung and its preparing process
08/26/1998CN1191123A Medicinal composition for treating bronchial asthma and its preparing process
08/26/1998CN1191122A Medicinal composition for treating chronic obstructive disease of lung and its preparing process
08/26/1998CN1191120A Antitussive plaster and its preparing method
08/26/1998CN1191119A Analgesic plaster and its preparing method
08/26/1998CN1191116A Oral snake liquid
08/26/1998CN1191115A Analgesic injection and its preparing method
08/26/1998CN1191083A 蛇胆茶 Snake tea
08/25/1998US5798238 Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer
08/25/1998US5798233 Functionally active lipooligosaccharide glycosyltransferase of neisseria gonorrhea
08/25/1998US5798216 Using a monoclonal antibody which binds to a glycoprotein ib-alpha polypeptide having a methionine-145 residue but does not bind to the polypeptide having a threonine-145 residue
08/25/1998US5798113 Grafting a vehicle containing core which contains isolated cells, either suspended in liquid or immobilized within hydrogel matrix, surrounded by a biocompatible jacket which protects isolated cells in core from immunological attack
08/25/1998US5798100 Multi-stage cascade boosting vaccine
08/25/1998US5798090 Enhancement of the cellular immune response
08/25/1998CA2117588C Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
08/25/1998CA2066699C Biomaterial based on collagen and its applications
08/25/1998CA2031522C Irradiation of blood products
08/25/1998CA1340012C Peptide determinant associated with immunity
08/20/1998WO1998036062A1 Neural cell adhesion molecule splicing variants
08/20/1998WO1998036055A1 Gene therapy for alleviating erectile dysfunction
08/20/1998WO1998036050A1 Clostridium butyricum having preventive and therapeutic effects on hepatopathy, and liver supporting agents, foods and feeds each containing the culture medium thereof
08/20/1998WO1998035985A1 Protein markers for lung cancer and use thereof
08/20/1998WO1998020146A3 Stabilized transient gene expression
08/20/1998CA2243984A1 Neural cell adhesion molecule splicing variants
08/20/1998CA2198050A1 Preparation for treatment of medical disorders and use thereof
08/19/1998EP0858506A2 Genetic induction of receptors for targeted radiotherapy
08/19/1998EP0858503A1 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS
08/19/1998EP0858502A1 Normal neural epithelial precursor cells
08/19/1998EP0858467A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
08/19/1998EP0858466A1 Use of protein gax for treating cancer
08/19/1998EP0858327A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases
08/19/1998EP0858267A1 Probiotically acting formulations
08/19/1998EP0752904B1 Body fluid filtration device and application thereof
08/19/1998EP0666770A4 Systems and methods for resuspending cellular-rich concentrates.
08/19/1998EP0460058B1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders
08/19/1998CN1190900A Method for reduction of the infrectiouseness of potentially infectious material
08/19/1998CN1190653A Process for one-stage extracting bilirubin
08/19/1998CN1190648A Process for preparing ionized ferro-zinc phosphorite amino-acid
08/19/1998CN1190591A Plaster for replenishing vital essence
08/19/1998CN1190590A Medicine for removing carbuncle and eliminating sore
08/19/1998CN1039541C Process for making nourishing wine
08/18/1998US5795909 DHA-pharmaceutical agent conjugates of taxanes
08/18/1998US5795861 Methods for regulating gastrointestinal motility
08/18/1998US5795781 Cell competency solution for use in the formation of a histologically-complete, living, human skin substitute
08/18/1998US5795768 Genetic engineering
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it
08/18/1998US5795573 Homeopathic pharmaceutical compositions
08/18/1998US5795571 Coagulation
1 ... 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 ... 1259